New York, NY -- (SBWIRE) -- 12/04/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Lowe's Companies, Inc (NYSE:LOW), Medical Marijuana Inc (OTCMKTS:MJNA)
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) showed a volume of 1.20 million shares by the end of last trade whereas the average volume of the stock remained 1.37 million shares. The stock opened the session at $3.33 but then moved to $3.23. At that price, the stock showed a negative performance of -0.31%. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
Will IMUC Get Buyers Even After The Recent Rally? Find Out Here
Lowe's Companies, Inc (NYSE:LOW) opened the session at $45.82 and closed the session at $46.50. The stock showed a negative performance of -0.70% in previous trading session. Traded with volume of 11.48 million shares in the prior session and the average volume of the stock remained 8.05 million shares. The beta of the stock remained 1.24. Lowe’s Companies, Inc. (Lowe’s) is a home improvement retailer. As of February 3, 2012, Lowe’s operated 1,745 stores, consisted of 1,712 stores across 50 United States, 31 stores in Canada and two stores in Mexico. Its 1,745 stores represent approximately 197 million square feet of retail selling space. The Company serves homeowners, renters and commercial business customers. Individual homeowners and renters complete an array of projects and vary along the spectrum of do-it-yourself (DIY) and do-it-for-me (DIFM).
Why Should Investors Buy LOW After the Recent Fall? Just Go Here and Find Out
Medical Marijuana Inc (OTCMKTS:MJNA) the stock decreased -4.55% and finished the session at $0.105. Traded with volume of 4.52 million shares in the prior session and the average volume of the stock remained 9.34 million shares. The beta of the stock remained 5.90. Medical Marijuana Inc. (MJNA) is the publicly held company vested in the medical marijuana and industrial hemp markets. It is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented and based cannabinoid products, to whole plant or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.
Will MJNA Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)